Medicines Act 1981

Dealings with medicines and medical devices

23A: Interpretation

You could also call this:

"What special words mean in the Medicines Act"

Illustration for Medicines Act 1981

When you read this part of the law, you need to know what some words mean. An applicant is a person who makes an application or has someone make it for them. You can find more information about applications in sections like section 23B and 23C. You will see words like "commencement date" which is the date when this section and others come into force. The law also talks about "confidential information" which includes trade secrets and other important business information. The law explains what an "innovative medicine application" is and how it relates to new medicines. It also defines a "protected period" which is a time when certain information is kept secret. Other important words are "WTO country" which means a country that is part of the World Trade Organization. The law has many specific definitions to help you understand it. The law refers to other sections like section 20 which is about the Minister's consent for medicines. You can find more details about these sections and how they work together.

This text is automatically generated. It might be out of date or be missing some parts. Find out more about how we do this.

This page was last updated on

View the original legislation for this page at https://legislation.govt.nz/act/public/1986/0120/latest/link.aspx?id=DLM55065.


Previous

23: Minister may give provisional consent, or

"The Minister can give temporary approval for a new medicine to be sold or used."


Next

23B: Protection of confidential supporting information about innovative medicines, or

"Keeping secret information about new medicines safe"

Part 2Dealings with medicines and medical devices

23AInterpretation

  1. In this section, and in sections 23B and 23C, unless the context otherwise requires,—

    applicant means—

    1. a person who makes or has made, as the case may be, an application; and
      1. a person on whose behalf an application is, or has been, made, as the case may be

        application means an application for the consent of the Minister under section 20, or for the provisional consent of the Minister under section 23, in relation to a medicine

          commencement date means the date this section and sections 23B and 23C come into force

            confidential information includes—

            1. trade secrets; and
              1. information with a commercial value that would, or would be likely to, be diminished by disclosure of the information

                confidential supporting information means confidential information given—

                1. in, or in relation to, an innovative medicine application; and
                  1. about the medicine that is or was, as the case may be, the subject of that application

                    ingredient includes a chemical or biological entity

                      innovative medicine application means,—

                      1. in relation to an application made after the commencement date, an application that refers to an active ingredient—
                        1. that is an active ingredient of the medicine to which the application relates; and
                          1. that has not, before that application is received by the Minister, been referred to in any other application (except in an application by the applicant for provisional consent for that medicine) as an active ingredient of a medicine; and
                          2. in relation to an application made before the commencement date, an application that referred to an active ingredient—
                            1. that is or was, as the case may be, an active ingredient of the medicine to which the application related; and
                              1. that had not, before that application was received by the Minister, been referred to in any other application (except in an application by the applicant for provisional consent for that medicine) as an active ingredient of a medicine

                              protected period means—

                              1. in relation to confidential supporting information, relating to an innovative medicine application, received by the Minister after the commencement date, a period commencing on the date that information is received by the Minister and ending,—
                                1. where—on the date 5 years after the date of that notification or refusal; or
                                  1. the Minister has given notice of consent, not being provisional consent, under section 20, or refused to give consent, in relation to the medicine that is the subject of the innovative medicine application; and
                                    1. the date of publication of the notice of consent or the date of the refusal is not more than 5 years after the Minister received an application in relation to that medicine,—
                                    2. in any other case, on the date 5 years after the innovative medicine application to which that information relates is or was, as the case may be, received by the Minister:
                                    3. in relation to confidential supporting information, relating to an innovative medicine application, received by the Minister not more than 5 years before the commencement date, a period commencing on the commencement date and ending,—
                                      1. where—on the date 5 years after the date of that notification or refusal; or
                                        1. the Minister has given or gives notice of consent, not being provisional consent, under section 20, or refused or refuses to give consent, in relation to the medicine that was the subject of the innovative medicine application; and
                                          1. the date of publication of the notice of consent or the date of the refusal is or was, as the case may be, not more than 5 years after the Minister received an application in relation to that medicine,—
                                          2. in any other case, on the date 5 years after the innovative medicine application to which that information related was received by the Minister

                                          WTO country means a country that is a party to the Agreement establishing the World Trade Organization adopted at Marrakesh on 15 April 1994.

                                          Notes
                                          • Section 23A: inserted, on , by section 2 of the Medicines Amendment Act 1994 (1994 No 128).
                                          • Section 23A confidential information: replaced, on , by section 11 of the Agricultural Compounds and Veterinary Medicines Amendment Act 2016 (2016 No 82).
                                          • Section 23A(a)(i)(A) protected period: replaced, on , by section 3 of the Secondary Legislation Act 2021 (2021 No 7).
                                          • Section 23A(a)(i)(B) protected period: amended, on , by section 3 of the Secondary Legislation Act 2021 (2021 No 7).
                                          • Section 23A(b)(i)(A) protected period: replaced, on , by section 3 of the Secondary Legislation Act 2021 (2021 No 7).
                                          • Section 23A(b)(i)(B) protected period: amended, on , by section 3 of the Secondary Legislation Act 2021 (2021 No 7).